Pain in Individuals With COPD During Pulmonary Rehabilitation
NCT ID: NCT02979379
Last Updated: 2022-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
68 participants
OBSERVATIONAL
2016-04-30
2020-03-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulmonary Rehabilitation, Dyspnoea and Emotional Cognition in COPD
NCT03092700
Single Leg Cycling in COPD: Knowledge Translation to Pulmonary Rehabilitation
NCT01930526
The CaNadian Standardized Pulmonary Rehabilitation Efficacy Trial
NCT02917915
Does Pulmonary Rehabilitation Change Self-Selected And Maximum Sustainable Walking Speed In Patients With Lung Disease?
NCT00781183
Muscle Activity and Sensation During Upright Partitioned Leg Exercise in COPD
NCT02613351
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Individuals with COPD who are beginning an out-patient PR program will be enrolled in the study. Those who report the presence of chronic pain will be classed as the pain group; those who report the absence of chronic pain will be classed as the comparator group. All participants will complete a 6-minute walk test and a Chronic Respiratory Disease Questionnaire (CRDQ) at the beginning of the PR program. These measures will be repeated at the end of the 8-week PR program for all participants. All participants will be asked to report their level of pain using a visual analogue scale every two weeks during the PR program.
Participants reporting chronic pain will also complete a series of questionnaires regarding their pain and coping strategies. These include; the Brief Pain Inventory (BPI), Coping Strategies Questionnaire (CSQ), Fear Avoidance Behavior Questionnaire (FABQ), Hospital Anxiety and Depression Scale (HADS) and Centre for Epidemiological Studies for Depression Survey (CES-D).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pain
Individuals with COPD who experience chronic pain (episodes of daily pain for a duration greater than three months)
Pain
No Pain
Individuals with COPD who do not experience pain on a regular basis.
Pain
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pain
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* clinically stable
* no history of acute exacerbation in the past 6 weeks
* able to provide their own informed consent
* referred to out-patient pulmonary rehabilitation at West Park Healthcare Centre
Exclusion Criteria
* known cognitive impairment that would interfere with completing surveys
* cardiac, neurological or orthopedic conditions which prevent the ability to undertake exercise safely
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
West Park Healthcare Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roger Goldstein
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West Park Healthcare Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-001-WP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.